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Introduction
Biomineralization of the ferrimagnetic iron oxide
magnetite (Fe3O4) is known to occur in a wide
variety of organisms (Kirschvink et al. 1985, Webb
et al. 1990). Many of these studies have focused 
on how these organisms (magnetotactic bacteria,
honey bees, birds and fish, for example) may use
biogenic magnetite particles for geomagnetic field
sensing – a behaviour known as magnetotaxis (for
review see Kobayashi & Kirschvink 1995). Recently,
however, attention has focused on the discovery 
and confirmation of the presence of biogenic
magnetite (Fe3O4) and maghemite (gFe2O3) in the
human brain (Kirschvink et al. 1992, Dobson et al.
1995, Dunn et al 1995, Kobayashi & Kirschvink 1995,
Dobson & Grassi 1996). This discovery is espe-
cially important in light of the fact that biogenic
magnetite may provide plausible mechanisms linking
human health effects to environmental electro-
magnetic field exposure (Kirschvink 1992, 1996,
Kobayashi & Kirschvink 1995, Dobson & St. Pierre
1996).
Although considerable research has been done on
bacteria and animals, much less is known about
humans. In fact, the role of biogenic magnetite in
the human central nervous system (CNS) is still not
understood. Comparison of the magnetic properties
of human brain tissue with those of the magneto-
tactic bacteria, Magnetospirillum magnetotacticum
(MV-1) and the dissimilatory iron-reducing bacteria,
Geobacter metallireducens (GS-15 – an anaerobic
microorganism, non-magnetotactic and non-motile)
has revealed that the material found in the human
brain behaves in a similar fashion to the magnetite
found in GS-15 (Dobson et al. 1995, Dunn et al. 1995,
Moskowitz et al. 1990). Although this does not rule
out the possibility of geomagnetic field sensing in
humans (either at present or as an evolutionary
relic), it does indicate that the biogenic magnetite
found in the human brain is not efficiently config-
ured for sensing using the same mechanism known
to be employed by other organisms.
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Isothermal remanent magnetization (IRM) acquisition and alternating field (A.F.) demagnetization analyses
were performed on human heart, spleen and liver samples resected from cadavers. The magnetic proper-
ties of the samples were measured both at 77K and at 273K. A.F. demagnetization was performed at 273K.
Results from the analyses of the tissue indicate the presence of ferromagnetic, fine-grained, magnetically
interacting particles which, due primarily to magnetic properties, are thought to be magnetite and/or
maghemite. The presence of superparamagnetic particles can be inferred from the increase in saturation
IRM values when measured at 77K compared with measurements at 273K and the decay of remanent magne-
tization upon warming from 77K. The concentration of magnetic material (assuming it is magnetite or
maghemite) in the samples varies from 13.7 ng g–1 to 343 ng g–1, with the heart tissue generally having the
highest concentration. The presence of magnetic material in these organs may have implications for the
function of biogenic magnetite in the human body.
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The purpose of this study is to investigate the mag-
netic properties of human organs other than the brain
– the heart (apex cordis dextra), spleen and liver – in
an attempt to determine the extent of magnetite/
maghemite biomineralization in humans and to
advance the understanding of its function. The
human lungs were not taken into consideration in this
study because of the possibility of exogenous mag-
netic contaminants, which are easy to assimilate by
breathing (Cohen 1973).
Methods
Tissue samples used in the study were resected from eight
cadavers during routine autopsies. All samples were taken
within 30 h after death and were not chemically fixed,
allowing a more accurate assessment of the magnetic
biominerals (Dobson & Grassi 1996). Contamination arte-
facts resulting from airborne contamination, the use of
surgical scalpels on the tissue, cauterization of blood
vessels and formalin fixing were previously examined and
controlled (Dobson & Grassi 1996).
The resected samples were immediately placed in vials
which had been soaked in a 30% HCl solution for at least
24 h, and put directly in liquid nitrogen to preserve the
chemistry. The samples were then placed in quartz glass
holders for magnetic measurement. These holders were
previously cleaned in 30% HCl for at least 24 h, and then
rinsed with distilled water. The samples were packed in
the holders with cellophane (found to be non-magnetic 
in separate analyses), to prevent movement during the
measurements. All empty holders were measured without
tissue prior to the tissue measurements so that their contri-
bution to the total magnetization could be subtracted from
the overall signal (as described in Dobson & Grassi 1996).
Acquisition of IRM of the samples was measured both
at 77K and at 273K. The samples were exposed to D.C.
magnetic fields in stepwise increments up to one Tesla (T)
at 77K using an Oxford Instruments water-cooled electro-
magnet. After each step the remanent magnetization was
measured on a 2G SQUID magnetometer. After the final
1T magnetization step, the samples were allowed to warm
to 273K. The samples were then completely demagnetised,
using an A.F. Schoensted Demagnetizer before being
remagnetized in steps up to 1T at 273K. Following this, the
samples were incrementally demagnetized and measured
with the SQUID magnetometer in order to generate
demagnetization curves.
The samples were weighed prior to measuring in order
to calculate the mass concentration of magnetic material
in the tissue. Tests to control for airborne contamination
in the laboratory, and for the reproducibility of the
measurements, were regularly carried out.
Results
IRM acquisition curves reveal the presence of low
coercivity magnetic material in all tissue samples
measured (Figure 1). All samples reached magnetic
saturation by 200 mT, which is consistent with 
the presence of magnetite and/or maghemite in the
tissue.
Calculations of the concentration of magnetic
material were performed assuming the material
responsible for the magnetization of the tissue was
biogenic magnetite. As maghemite has similar mag-
netic properties, the calculated concentrations would
be only slightly different if the presence of that
mineral represented some fraction of the overall
magnetization in the tissue (the saturation magneti-
zation for magnetite is 476 Am–1 while that of
maghemite is 426 Am–1 – Merrill & McElhinney
1983). These calculations show that concentrations
range from 14 ng g–1 to more than 300 ng g–1, with
the heart samples generally having the highest
concentration (Table 1). With the exception of
sample 96/268, the liver and spleen concentrations
were broadly in the same range as human brain
tissue. The heart samples, however, have concen-
trations which are generally about five to ten times
higher than brain tissue.
Alternating field demagnetization of IRM shows
that the samples have R values (Wohlfahrt ratios –
the ratio of saturation IRM demagnetized to the
remanent coercive force value to the undemagne-
tized saturation IRM) less than 0.5, indicating that
the grains are magnetically interacting (Figure 2).
The characteristics of these curves (R values and
Median Coercivites) are similar to those reported
from brain tissue samples (Kirschvink et al. 1992,
Dunn et al. 1995, Dobson & Grassi 1996).
Comparison of IRM acquisition curves measured
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Figure 1. Examples of IRM acquisition curves for 
heart, liver and spleen tissue measured at 77K. M is the
remanent magnetization.
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Table 1. Weight in grams, saturation remanent magne-
tization (Jr–measured at 77K) and calculated magnetite/
maghemite concentrations for all heart, spleen and liver
samples
Sample Weight (g) Jr (Am2 kg–1) Concentration 
(ng g–1)
Heart
96/245 1.236 1.58E-05 343
96/268 0.768 4.70E-06 102
96/515 1.340 9.26E-06 201
96/549 0.570 1.13E-05 245
96/624 0.440 5.72E-06 124
96/674 0.193 7.78E-06 169
97/025 0.413 5.06E-06 110
Spleen
96/245 1.466 1.07E-06 23.3
96/268 1.493 1.42E-05 308
96/425 0.778 7.70E-07 16.7
96/515 1.129 1.69E-06 36.7
96/549 1.368 6.34E-07 13.7
96/614 0.783 3.88E-06 84.3
96/674 1.019 1.94E-06 42.2
Liver
96/245 1.695 2.40E-06 52.2
96/268 1.387 7.30E-06 158
96/425 0.961 1.54E-06 33.5
96/515 0.979 1.68E-06 36.5
96/549 1.160 1.70E-06 36.9
96/624 1.448 3.56E-06 77.4
96/674 1.112 5.06E-06 110
97/025 0.729 1.62E-06 35.2
Figure 2. IRM acquisition and AF demagnetization for
heart sample 96/674 at 273K. The R value (see text for
explanation) is 0.23 and the Median Coercivity is 32 mT.
M is the remanent magnetization 
Figure 3. IRM acquisition curves for samples from: (a)
liver; (b) spleen; and (c) heart measured at both 77K and
273K. M is the remanent magnetization
at 77K and 273K show that there is a difference 
in saturation remanent magnetization at the two
temperatures (Figure 3). The significance of this will
be discussed in the next section.
Discussion and conclusions
The IRM acquisition and AF demagnetization
curves indicate that ferro or ferrimagnetic, fine-
grained, magnetically interacting particles are
present in varying concentrations in all tissue
samples measured. The magnetic properties of the
tissue are consistent with the material being biogenic
magnetite and/or maghemite. The presence of these
iron biominerals in the human brain and other
organisms has been reported previously but they
have not been observed in the human heart, spleen
and liver.
Earlier magnetic investigations of these organs
(particularly the spleen and liver) have revealed 
the presence of the iron biomineral hemosiderin 
(for review see St. Pierre et al. 1989). Although this
material is thought to be antiferromagnetic (though
this is still unresolved) and known to occur in 
several forms (especially in the liver and spleen),
none of the forms would be likely to contribute to
the magnetization of this tissue when measuring
isothermal remanence – especially at 273K.
Mössbauer analysis of hemosiderin in the liver
and spleen reveals that the maximum blocking
temperature for this iron oxyhydroxide is 150K on
a time scale of 10–8 to 10–9 seconds (St. Pierre et al.
1989). Even if it is antiferromagnetic with a defect
moment, any hemosiderin present in the tissue
therefore, would not contribute to the overall rema-
nent magnetization, as even 77K would be above its
blocking temperature at the time scale of the IRM
measurements (several seconds per measurement).
Previous Mössbauer investigations of these organs,
however, would not have shown evidence of the
presence of biogenic magnetite and/or maghemite 
as the concentrations are three to four orders 
of magnitude too low for resolution using this 
technique.
The presence of superparamagnetic particles in
the tissue can be inferred from the increase in satu-
ration IRM values when measured at 77K compared
with measurements at 273K, as more superpara-
magnetic grains will become magnetically blocked
as energy available for thermal agitation is removed
from the system. These particles are magnetic but
of very small grain size and consequently have very
short relaxation times. Magnetic relaxation time 
is temperature dependent and will increase as 
the particles are cooled. As the relaxation time
increases, the magnetization becomes stable on the
time scales required for the measurement. This is an
indication that there is a range of grain sizes present
in the tissue.
Calculated concentrations of magnetic material in
the tissue are generally consistent within each organ
type, with heart tissue having the highest concen-
trations. There was, however, one anomalous result
– 96/268. It is not clear why the concentrations in
this spleen and liver are so much higher than in the
other samples. There was no observed pathology in
either of the organs and all samples were handled
in the same manner as our previous studies of brain
tissue in order to avoid sources of contamination and
artefacts (Dobson & Grassi 1996). It is therefore not
likely that the magnetic material in these samples
represents contamination due to airborne particles
or surgical instruments.
Although all of the evidence presented here indi-
cates that biogenic magnetite and/or maghemite
likely is present in human organs other than the
brain, in order to confirm these results it will be
necessary in the future to extract and directly
observe these particles using electron microscopy.
Recent studies indicate that exposure to electro-
magnetic fields may have an influence on coronary
heart disease in railway workers (Ptitsyna et al. 1996).
As biogenic magnetite provides a possible mecha-
nism for interactions of weak magnetic fields with the
human brain (Kirschvink 1992, 1996, Dobson & St.
Pierre 1996) it is important to examine its presence
and understand its role in other human organs as well.
Finding biogenic magnetite in organs other than
the brain is a further indication that it may not have
a role in geomagnetic field sensing in humans as this
function would normally involve the central nervous
system. It may represent another iron storage mech-
anism for the body; however, at this point the role
of magnetite in humans is still unknown.
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